Creighton Healthcare | Auto Injury & Medical Spa

Creighton Healthcare | Auto Injury & Medical Spa operates in Tampa, Florida, providing medical weight management programs centered on GLP-1 receptor agonist therapy. The clinic has established a focused practice model that combines semaglutide-based weight loss protocols with complementary body contouring services, addressing both metabolic health and aesthetic concerns for patients throughout the Tampa Bay area. With a 4.7-star rating across 87 Google reviews, the practice has built a reputation for structured weight management programs that integrate pharmaceutical intervention with ongoing clinical monitoring.

The clinic's primary peptide offering is semaglutide, a glucagon-like peptide-1 (GLP-1) analog that regulates appetite and glucose metabolism. Creighton Healthcare administers semaglutide through subcutaneous injection protocols, typically starting patients at lower doses and titrating upward based on individual tolerance and weight loss response. The medical team conducts baseline metabolic assessments before initiating therapy, including body composition analysis and review of contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients receive instruction on proper injection technique, needle disposal, and recognition of potential side effects including nausea, constipation, and changes in digestion. The Tampa clinic schedules regular follow-up appointments to monitor weight trends, adjust dosing, and address any emerging concerns during the treatment course.

Creighton Healthcare's providers bring clinical experience in both injury rehabilitation and aesthetic medicine to their weight management programs. This dual focus allows the practice to address patients who may be dealing with mobility limitations from prior auto injuries while simultaneously pursuing weight loss goals. The medical staff evaluates each patient's activity level, injury history, and metabolic baseline to create individualized treatment plans that account for physical limitations. For patients cleared for increased activity, the clinic provides guidance on exercise progression that complements semaglutide therapy without exacerbating existing musculoskeletal conditions. Hormone therapy services are also available for patients whose weight management challenges may be influenced by thyroid dysfunction, testosterone deficiency, or estrogen imbalance, though these require separate evaluation and laboratory confirmation.

Patients beginning semaglutide treatment at the Tampa location typically start with an initial consultation that includes medical history review, current medication assessment, and discussion of realistic weight loss expectations. The clinic emphasizes that semaglutide is most effective when combined with dietary modifications and increased physical activity, not as a standalone solution. Treatment protocols generally span several months, with weekly injections and monthly check-ins to assess progress. Body sculpting services such as non-invasive fat reduction and skin tightening procedures are available as adjunctive treatments for patients who have achieved significant weight loss and are addressing residual aesthetic concerns. The practice maintains clear communication about the difference between medical weight loss through peptide therapy and cosmetic body contouring, ensuring patients understand which interventions address metabolic health versus appearance.

Creighton Healthcare serves the greater Tampa area from its Florida location, providing accessible medical weight management for residents seeking pharmaceutical support for obesity or overweight conditions with comorbidities. The clinic accepts consultations for new patients interested in semaglutide therapy and conducts eligibility screening based on BMI criteria and medical history. While the practice operates as a medical spa with aesthetic services, its weight loss programs follow clinical protocols with appropriate medical oversight, laboratory monitoring, and documentation of treatment response. Patients should expect ongoing costs for medication, injection supplies, and follow-up visits throughout their treatment duration, as GLP-1 therapy requires consistent administration to maintain appetite suppression and weight loss effects.